Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301)
Clinical trial NCT06846515 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06846515
- Sponsor
- Arthrosi Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-11
- Primary completion
- 2026-09-01
- Enrollment
- 750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.